Dinutuximab (Anti-GD2)
Dinutuximab (Anti-GD2) is a chimeric mouse/human monoclonal antibody that targets ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. It has potential antineoplastic activity. MW: 145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2485 |
| Sku # | A2485-1mg*25 |
| Pricing | 1mg*25, $5070.00 |